126 related articles for article (PubMed ID: 17692217)
21. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
Musolino A; Boggiani D; Panebianco M; Vasini G; Salvagni S; Franciosi V; Ardizzoni A
Cancer; 2011 Mar; 117(5):964-73. PubMed ID: 20960528
[TBL] [Abstract][Full Text] [Related]
22. Multivariate analysis of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma: data from the INC-EU Prospective Observational European Neutropenia Study.
Pettengell R; Bosly A; Szucs TD; Jackisch C; Leonard R; Paridaens R; Constenla M; Schwenkglenks M;
Br J Haematol; 2009 Mar; 144(5):677-85. PubMed ID: 19055662
[TBL] [Abstract][Full Text] [Related]
23. Cardiovascular adverse events in patients with non-Hodgkin lymphoma treated with first-line cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP with rituximab (R-CHOP): a systematic review and meta-analysis.
Linschoten M; Kamphuis JAM; van Rhenen A; Bosman LP; Cramer MJ; Doevendans PA; Teske AJ; Asselbergs FW
Lancet Haematol; 2020 Apr; 7(4):e295-e308. PubMed ID: 32135128
[TBL] [Abstract][Full Text] [Related]
24. Treatment of localized lymphoma.
Tanvetyanon T
N Engl J Med; 2005 Jun; 352(23):2449-51; author reply 2449-51. PubMed ID: 15944432
[No Abstract] [Full Text] [Related]
25. High-dose sequential (HDS) chemotherapy for high-risk non-Hodgkin's lymphoma: long-term analysis and future developments.
Tarella C; Cuttica A; Caracciolo D; Zallio F; Ricca I; Bergui L; Gavarotti P; Marinone C; Pagano M; Rossi G; de Crescenzo A; Salomone A; Ladetto M; Boccadoro M; Pileri A
Ann Hematol; 2001; 80 Suppl 3():B123-6. PubMed ID: 11757693
[No Abstract] [Full Text] [Related]
26. Neurological syndrome after R-CHOP chemotherapy for a non-Hodgkin lymphoma: what is the diagnosis?
Marino D; Farina P; Jirillo A; De Franchis G; Simonetto M; Aversa SM
Int J Hematol; 2011 Nov; 94(5):461-2. PubMed ID: 21993875
[TBL] [Abstract][Full Text] [Related]
27. Influence of rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone on serologic parameters and clinical course in lymphoma patients with autoimmune diseases.
Wöhrer S; Troch M; Zwerina J; Schett G; Skrabs C; Gaiger A; Jaeger U; Zielinski CC; Raderer M
Ann Oncol; 2007 Apr; 18(4):647-51. PubMed ID: 17218490
[TBL] [Abstract][Full Text] [Related]
28. Incidence of interstitial pneumonitis in non-Hodgkin's lymphoma patients receiving immunochemotherapy with pegylated liposomal doxorubicin and rituximab.
Zhou T; Shen Q; Peng H; Chao T; Zhang L; Huang L; Yang K; Thapa S; Yu S; Jiang Y
Ann Hematol; 2018 Jan; 97(1):141-147. PubMed ID: 29086009
[TBL] [Abstract][Full Text] [Related]
29. Chemoradiotherapy for localized non-Hodgkin's lymphoma.
Cosset JM
N Engl J Med; 1998 Jul; 339(1):44-5. PubMed ID: 9647881
[No Abstract] [Full Text] [Related]
30. A rare diagnosis of pancreatic tumour.
Chung CS; Liao WC; Wang HP
Gut; 2009 Feb; 58(2):188, 248. PubMed ID: 19136521
[No Abstract] [Full Text] [Related]
31. Generalized granuloma annulare and non-Hodgkin's lymphoma.
Bassi A; Scarfi F; Galeone M; Arunachalam M; Difonzo E
Acta Derm Venereol; 2013 Jul; 93(4):484-5. PubMed ID: 23250047
[No Abstract] [Full Text] [Related]
32. [Treatment of elderly patients with non-Hodgkin's lymphoma].
Titorenko IB; Kriachok IA
Lik Sprava; 2011; (5-6):79-85. PubMed ID: 22606896
[TBL] [Abstract][Full Text] [Related]
33. Herpes simplex virus-related oral mucositis in patients with lymphoma.
Guerrero MD; Swenson KK
Oncol Nurs Forum; 2014 May; 41(3):327-30. PubMed ID: 24769598
[TBL] [Abstract][Full Text] [Related]
34. Impact of body mass index on incidence of febrile neutropenia and treatment-related mortality in United States veterans with diffuse large B-cell lymphoma receiving rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone.
Ganti A; Liu W; Luo S; Sanfilippo KM; Roop R; Lynch R; Riedell P; O'Brian K; Colditz GA; Carson KR
Br J Haematol; 2014 Dec; 167(5):699-702. PubMed ID: 25040880
[No Abstract] [Full Text] [Related]
35. Cyclophosphamide, doxorubicin, vincristine, methotrexate, bleomicin and prednisone plus rituximab in untreated young patients with low-risk (age-adjusted international prognostic index 0-1) diffuse large B-cell lymphoma.
Derenzini E; Stefoni V; Pellegrini C; Fina MP; Broccoli A; Venturini F; Gandolfi L; Pileri SA; Martelli M; Petti MC; Perrotti A; De Renzo A; Zaja F; Baccarani M; Zinzani PL
Leuk Lymphoma; 2009 Nov; 50(11):1824-9. PubMed ID: 19814687
[TBL] [Abstract][Full Text] [Related]
36. A case of facial swelling and proptosis.
Rahman S; Rahman W; Rahman F
Dent Update; 2004 Nov; 31(9):553-4. PubMed ID: 15612462
[TBL] [Abstract][Full Text] [Related]
37. Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy.
Decker M; Rothermundt C; Holländer G; Tichelli A; Rochlitz C
Lancet Oncol; 2006 Aug; 7(8):693-4. PubMed ID: 16887487
[No Abstract] [Full Text] [Related]
38. Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study.
Robak T; Jin J; Pylypenko H; Verhoef G; Siritanaratkul N; Drach J; Raderer M; Mayer J; Pereira J; Tumyan G; Okamoto R; Nakahara S; Hu P; Appiani C; Nemat S; Cavalli F;
Lancet Oncol; 2018 Nov; 19(11):1449-1458. PubMed ID: 30348538
[TBL] [Abstract][Full Text] [Related]
39. Minimizing toxicity of MACOP-B.
Connors JM; Klimo P
J Clin Oncol; 1987 Aug; 5(8):1302-3. PubMed ID: 2442319
[No Abstract] [Full Text] [Related]
40. Rituximab combined with MACOP-B or VACOP-B and radiation therapy in primary mediastinal large B-cell lymphoma: a retrospective study.
Zinzani PL; Stefoni V; Finolezzi E; Brusamolino E; Cabras MG; Chiappella A; Salvi F; Rossi A; Broccoli A; Martelli M
Clin Lymphoma Myeloma; 2009 Oct; 9(5):381-5. PubMed ID: 19858058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
